Effect of olanzapine on behavioural changes induced by FG 7142 and dizocilpine on active avoidance and plus maze tasks

Brain Research

Volumn 830, Issue 2, 1999, Pages 337-344

  Ninan, Ipe ^a   Kulkarni, Shrinivas K ^a  

^a PANJAB UNIVERSITY   (India)

Author keywords

Active avoidance paradigm; Cognition; Dizocilpine; Elevated plus maze; FG 7142; Olanzapine

Indexed keywords

DIZOCILPINE; N METHYL BETA CARBOLINE 3 CARBOXAMIDE; OLANZAPINE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AVOIDANCE BEHAVIOR; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; DOPAMINERGIC ACTIVITY; DOSE RESPONSE; DRUG EFFECT; LATENT PERIOD; LOCOMOTION; MALE; MAZE TEST; MEMORY CONSOLIDATION; MOUSE; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; SCHIZOPHRENIA;

ANIMALS; ANTIPSYCHOTIC AGENTS; AVOIDANCE LEARNING; BENZODIAZEPINES; CARBOLINES; DIZOCILPINE MALEATE; EXCITATORY AMINO ACID ANTAGONISTS; MALE; MAZE LEARNING; MICE; MICE, INBRED BALB C; PIRENZEPINE; REACTION TIME;

EID: 0033526577     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(99)01422-5     Document Type: Article

References (55)

1. Arnsten A.F.T. Catecholamine regulation of prefrontal cortex. J. Psychopharmacol. 11:1997;151-162.
2. 1 receptor mechanisms in the cognitive performance of young adult and aged monkeys. Psychopharmacology. 116:1994;143-151.
3. Arnsten A.F.T., Goldman-Rakic P.S. Stress impairs prefrontal cortex cognitive function in monkeys: role of dopamine. Soc. Neurosci. Abstr. 16:1990;164.
4. Arnt J., Skarsfeldt T. Do novel antipsychotics have similar pharmacological characteristics? A review of the evidence. Neuropsychopharmacology. 18:1998;63-101.
5. The Olanzapine HGAD Study Group, Beasley C.M., Tollefson G.D., Tran P., Satterlee W., Sanger T., Hilman S. Olanzapine vs. placebo and haloperidol: acute phase results of the North American double blind olanzapine trial. Neuropsychopharmacology. 14:1996;111-123.
6. Bebbington P., Wilkins S., Jones P., Foerster A., Murray R., Toone B., Shon L. Life events and psychosis: initial results from the Camberwell collaborative psychosis study. Br. J. Psychiatry. 162:1993;72-79.
7. Benvenga M.J., Spaulding T.C. Amnesic effect of the novel anticonvulsant MK-801. Pharmacol. Biochem. Behav. 30:1988;205-207.
8. Bersani G., Venturi P., Tanfani G., Pancheri P. Cerebral ventricular enlargement and neuroleptic response in chronic schizophrenia: preliminary findings with risperidone. Hum. Psychopharmacol. Clin. Exp. 10:1995;53-58.
9. Borozoski T., Brown K.M., Rosvold H.E., Goldman-Rakic P.S. Cognitive deficit caused by regional depletion of dopamine in prefrontal cortex of rhesus monkey. Science. 205:1979;929-931.
10. Bracs P.U., Gregory P., Jackson D.M. Passive avoidance in rats: disruption by dopamine applied to the nucleus accumbens. Psychopharmacology. 83:1984;70-75.
11. A. Breier, O.M. Wolkowitz, D. Pickar, Stress and schizophrenia: advances in neuropsychiatry and psychopharmacology, in: C.A. Tamminga, S.C. Schult (Eds.), Schizophrenia Research, Vol. 1, Raven Press, New York, 1991, pp. 141-152.
12. Buchanan R.W., Holstein C., Breier A. The comparative efficacy and long-term effect of clozapine treatment on neuropsychological test performance. Biol. Psychiatry. 36:1994;717-725.
13. Butelman E.R. A novel NMDA antagonist, MK-801, impairs performance in a hippocampal-dependent spatial learning task. Pharmacol. Biochem. Behav. 34:1989;13-16.
14. Bymaster F.P., Calligaro D.O., Falcone J.F., Marsh R.D., Moore N.A., Tye N.C., Seeman P., Wong D.T. Radioreceptor binding profile of the atypical antipsychotic olanzapine. Neuropsychopharmacology. 14:1996;87-96.
15. Casey D.E. The relationship of pharmacology to side effects. J. Clin. Psychiatry. 58:1997;55-62.
16. Deutch A.Y., Roth R.H. The determinants of stress-induced activation of the prefrontal cortical dopamine system. Prog. Brain. Res. 85:1990;367-403.
17. Deutch A.Y. The regulation of subcortical dopamine systems by the prefrontal cortex: interactions of central dopamine systems and the pathogenesis of schizophrenia. J. Neural Transm. 36:1992;61-89.
18. Dolan R.J., Fletcher P.C., Frith C.D., Friston K.J., Frackwiak R.S.J., Grasby P.M. Dopaminergic modulation of impaired cognitive activation of the anterior cingulate cortex in schizophrenia. Nature. 378:1995;180-182.
19. Fernanddez-Tome M.P., Sanchez-Blazquez P., del Rio J. Impairment by apomorphine of one-trial passive avoidance learning in mice: the opposing roles of the dopamine and noradrenaline systems. Psychopharmacology. 61:1979;43-47.
20. Gattaz W.F., Schummer B., Behrens S. Effects of zotepine, haloperidol and clozapine on MK-801-induced stereotypy and locomotion in rats. J. Neural Transm.: Gen. Sect. 96:1994;227-232.
21. P.S. Goldman-Rakic, Prefrontal cortical dysfunction in schizophrenia: the relevance of working memory, in: B.J. Caroll, J.E. Barett (Eds.), Psychopathology and the Brain, Raven Press, New York, 1991, pp. 1-23.
22. Hoffman D.C. Typical and atypical neuroleptics antagonise MK-801-induced locomotion and stereotypy in rats. J. Neural Transm.: Gen. Sect. 89:1992;1-10.
23. Ichihara K., Nabeshima T., Kameyama T. Opposite effects induced by low and high doses of apomorphine on single-trial passive avoidance learning in mice. Pharmacol. Biochem. Behav. 30:1987;107-113.
24. Irifune M., Shimizu T., Nomoto M. Ketamine-induced hyperlocomotion associated with alteration of presynaptic components of dopamine neurons in the nucleus accumbens of mice. Pharmacol. Biochem. Behav. 40:1991;399-407.
25. Itoh J., Nabeshima T., Kameyama T. Utility of an elevated plus maze for the evaluation of memory in mice: effect of nootropics, scopolamine and electroconvulsive shock. Psychopharmacology. 101:1990;27-33.
26. Koek W., Colpaert F.C., Woods J.H., Kamenka J.M. The phencyclidine (PCP) analogue N-[1-(2-benzo(b)thiophenyl)cyclohexyl]piperidine shares cocaine-like but not other characteristic behaviour effects with PCP, ketamine and MK-801. J. Pharmacol. Exp. Ther. 250:1989;1019-1027.
27. Levin S. Frontal lobe dysfunction in schizophrenia: II. Impairments of psychological and brain functions. J. Psychiatr. Res. 18:1984;27-55.
28. 1A receptor antagonist, (+)-WAY 100135, on stereotyped behaviour induced by the NMDA receptor antagonist dizocilpine in rats. Eur. J. Pharmacol. 242:1993;99-104.
29. Mathe J.M., Nomikos G.G., Hildebrand B.E., Hertel P., Svensson T.H. Prazocin inhibits MK-801-induced hyperlocomotion and dopamine release in the nucleus accumbens. Eur. J. Pharmacol. 309:1996;1-11.
30. Moore N.A., Calligaro D.O., Wong D.T., Bymaster F.P., Tye N.C. The pharmacology of olanzapine and other new antipsychotic agents. Curr. Opin. Invest. Drugs. 2:1993;181-293.
31. Murphy B.L., Arnsten A.F.T., Goldman-Rakic P.S., Roth R.H. Increased dopamine turnover in the prefrontal cortex impairs spatial working memory performance in rats and monkeys. Proc. Nat. Acad. Sci. USA. 93:1996;1325-1329.
32. Murphy B.L., Roth R.H., Arnsten A.F.T. The effects of FG 7142 on prefrontal cortical dopamine and spatial working memory in rat and monkey. Soc. Neurosci. Abstr. 20:1994;1019.
33. Murphy B.L., Roth R.H., Arnsten A.F.T. Clozapine reverses the spatial working memory deficits induced by FG 7142 in monkeys. Neuropsychopharmacology. 16:1997;433-437.
34. Ninan I., Kulkarni S.K. Clozapine-induced cognitive dysfunction in mice. Methods Find. Exp. Clin. Pharmacol. 18:1996;367-372.
35. 2 receptors in dopamine depleted animals. Psychopharmacology. 135:1998;311-317.
36. 2 receptors! Psychopharmacology. 138:1998;215-216.
37. 2 receptors in dopamine depleted animals. Psychopharmacology. 142:1999;175-181.
38. Ninan I., Kulkarni S.K. Dopamine receptor sensitive effect of dizocilpine on feeding behaviour. Brain Res. 812:1998;157-163.
39. 2A receptor antagonists block MK-801-induced stereotypy and hyperlocomotion. Eur. J. Pharmacol. 358:1998;111-116.
40. Ninan I., Kulkarni S.K. Preferential blockade by clozapine of hyperlocomotion induced by non-competitive NMDA antagonist MK-801. Ind. J. Physiol. Pharmacol. 42:1998;375-382.
41. Ninan I., Kulkarni S.K. Preferential inhibition of dizocilpine-induced hyperlocomotion by olanzapine. Eur. J. Pharmacol. 368:1999;1-7.
42. Reddy D.S., Kulkarni S.K. Possible role of nitric oxide in the nootropic and antiamnesic effects of neurosteroids on ageing- and dizocilpine-induced learning impairment. Brain Res. 799:1998;215-229.
43. 1 dopamine receptors in prefrontal cortex: involvement in working memory. Science. 251:1991;947-950.
44. Sharma A.C., Kulkarni S.K. Effects of MK-801 and ketamine on short-term memory deficits in passive avoidance step-down task paradigm in mice. Methods Find. Exp. Clin. Pharmacol. 13:1991;155-159.
45. Thierry A.M., Tassin J.P., Blanc G., Glowinsky J. Selective activation of the mesocortical DA system by stress. Nature. 263:1976;242-244.
46. Tollefson G.D. Cognitive function in schizophrenic patients. J. Clin. Psychiatry. 57:1996;31-39.
47. Uchihashi Y., Kuribara H., Isa Y., Morita T., Sato T. The disruptive effects of ketamine on passive avoidance learning in mice: involvement of dopaminergic mechanism. Psychopharmacology. 116:1994;40-44.
48. Verma A., Kulkarni S.K. Modulation of MK-801 response by dopaminergic agents in mice. Psychopharmacology. 107:1991;432-436.
49. Verma A., Moghaddam B. NMDA receptor antagonists impair prefrontal cortex function as assessed by spatial delayed alternation performance in rats: modulation by dopamine. J. Neurosci. 16:1996;373-379.
50. Weinberger D.R., Berman K.F., Zee R.F. Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia: I. Regional cerebral blood flow evidence. Arch. Gen. Psychiatry. 43:1986;114-124.
51. 1 receptors in prefrontal cortex. Nature. 376:1995;572-575.
52. Wong E.H.F., Kemp J.A., Priestley T., Knight A.R., Woodruff G.N., Iverson L.L. The anticonvulsant MK-801 is a potent N-methyl-D-aspartate antagonist. Proc. Natl. Acad. Sci. USA. 83:1986;7104-7108.
53. Wong E.H.F., Woodruff G.N. The identification of a novel binding site for the anticonvulsant, MK-801, in rat brain membranes. Br. J. Pharmacol. Proc. Suppl. 89:1986;530P.
54. Woodruff G.N., Foster A.C., Gill R., Kemp J.A., Wong E.H.F., Iverson L.L. The interacion between MK-801 and receptors for N-methyl-D-aspartate: functional consequences. Neuropharmacology. 26:1987;903-909.
55. 1 receptors in the prefrontal cortex impairs spatial working memory in rats. Soc. Neurosci. Abstr. 22:1996;1128.